US Patent Issued to TSD LIFE SCIENCES on Feb. 10 for "Imidazopyridine derivative and pharmaceutical composition comprising same as active ingredient" (South Korean Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,673, issued on Feb. 10, was assigned to TSD LIFE SCIENCES Co. LTD. (Seoul, South Korea).

"Imidazopyridine derivative and pharmaceutical composition comprising same as active ingredient" was invented by Jae Won Lee (Seoul, South Korea), Do Hyun Son (Namyangju-si, South Korea), Nam Sook Kang (Daejeon, South Korea) and Sung Wook Choi (Daejeon, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an imidazopyridine derivative and a pharmaceutical composition comprising same as an active ingredient and, more particularly, to an imidazopyridine derivative that inhibits protein kinase activity and as such, can be used...